Treprostinil S.K 5 MG/ML Primary pulmonary arterial hypertension.
Pulmonary arterial hypertension associated with connective tissue disorders.
Pulmonary hypertension associated with congenital systemic to pulmonary shunts.
Treprostinil s.k. is indicated for the treatment of:
- Primary pulmonary arterial hypertension.
- Pulmonary arterial hypertension is associated with connective tissue disorders.
- Pulmonary hypertension is associated with congenital systemic to pulmonary shunts.
**Disclaimer:
The images and designs presented on this website are for illustrative purposes only. Actual products may differ from those shown, including variations in color, packaging design, wording, or other visual features. The company assumes no responsibility for any such discrepancies and does not undertake to update the website to reflect changes in the actual product.
*** Disclaimer
The information provided herein is not intended as medical advice and must not be relied upon for diagnosis, treatment, or the provision of medical care. It does not replace the official prescribing/patient leaflet or consultation with a qualified healthcare professional. Before any use, always review the official physician/patient leaflet and consult a licensed physician. The company assumes no responsibility or liability for any reliance placed on the information presented on this page.
